These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone. Sotomayor S, Carmena MJ, Schally AV, Varga JL, Sánchez-Chapado M, Prieto JC, Bajo AM. Int J Oncol; 2007 Nov; 31(5):1223-30. PubMed ID: 17912451 [Abstract] [Full Text] [Related]
5. IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1. Fernández M, Sánchez-Franco F, Palacios N, Sánchez I, Cacicedo L. J Mol Endocrinol; 2005 Jun; 34(3):699-712. PubMed ID: 15956341 [Abstract] [Full Text] [Related]
6. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K. Gutiérrez-Cañas I, Juarranz MG, Collado B, Rodríguez-Henche N, Chiloeches A, Prieto JC, Carmena MJ. Prostate; 2005 Apr 01; 63(1):44-55. PubMed ID: 15468165 [Abstract] [Full Text] [Related]
7. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R. Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977 [Abstract] [Full Text] [Related]
8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N. Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430 [Abstract] [Full Text] [Related]
9. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C. Cancer Res; 2002 Nov 01; 62(21):6039-44. PubMed ID: 12414626 [Abstract] [Full Text] [Related]
10. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S, Agoulnik IU, Weigel NL. Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350 [Abstract] [Full Text] [Related]
11. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide. Rekasi Z, Schally AV, Plonowski A, Czompoly T, Csernus B, Varga JL. Prostate; 2001 Aug 01; 48(3):188-99. PubMed ID: 11494334 [Abstract] [Full Text] [Related]
18. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z. Cancer Res; 1998 Oct 15; 58(20):4640-5. PubMed ID: 9788616 [Abstract] [Full Text] [Related]